ArticleNPJ digital medicine2026
Overcoming Data Loss in Wearable Disease Detection with GAN-Based Imputation.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
High rates of missing data in wearable sensor streams hinder early detection of infectious diseases, especially in low-resource settings with inconsistent device adherence and connectivity. We developed a lightweight generative adversarial network (GAN) framework that imputes missing heart rate data and integrates with a rule-based anomaly detection algorithm to identify early signs of infection. In a cohort from rural Kenya (n = 300, 161 malaria-positives), our system triggered early alerts in 100 cases, including 42 solely with imputation. Alerts preceded symptom onset by 11.9 days, aligning with the 11.7-day parasitemia window from controlled trials. Despite 50% data coverage, alerts occurred on 3.5 consecutive days during the infection window, improving early detection by 35%. The GAN, trained only on external COVID-19 data (n = 3318), generalized to malaria, reducing reconstruction error by 58%. This approach demonstrates scalable, cross-pathogen physiological monitoring and offers a robust tool for disease surveillance in settings challenged by high wearable data loss.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.